Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data



Rating:

Share or cite this content

Citations should be made in the following way:
N. Godtfredsen (Hvidovre, Denmark), M. Damkjær (Hvidovre, Denmark), K. Håkansson (Hvidovre, Denmark), T. Kallemose (Hvidovre, Denmark), C. Ulrik (Hvidovre, Denmark). No impact of statins on time to first COPD exacerbation or all-cause mortality. 2407

Member's Comments

No comment yet.

Related content which might interest you: Prior cardiovascular disease increases long-term mortality in COPD patients with pneumonia Source: Eur Respir J 2014; 43: 36-42 Year: 2004 Predictors of mortality in COPD patients after hospitalization due to an exacerbation Source: International Congress 2019 – Exacerbations of airway diseases Year: 2019 The impact on risk-factor analysis of different mortality outcomes in COPD patients Source: Eur Respir J 2008; 32: 629-636 Year: 2008 Tiotropium and the risk of cardiovascular events and all-cause mortality Source: Annual Congress 2010 - Comorbidities and disease management in primary care Year: 2010 Trends in the lifetime risk of COPD exacerbation requiring hospitalisation Source: Eur Respir J 2013; 42: 964-971 Year: 2013 Predictors of mortality in COPD Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects Year: 2008 Predictors of mortality in COPD Source: Annual Congress 2009 - Prognosis and comorbidities in COPD Year: 2009 In hospitalized COPD exacerbation (COPDE) patients a 30-day readmission is associated with a progressive increased risk of mortality Source: International Congress 2015 – COPD: interesting notes Year: 2015 Predictors of mortality in COPD during acute exacerbation Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment Year: 2009 Statins and outcome of COPD patients after hospitalization for COPD exacerbations Source: Annual Congress 2010 - New treatments for asthma and COPD Year: 2010 Inhaled corticosteroid therapy reduces the risk of rehospitalization and all-cause mortality in elderly asthmatics Source: Eur Respir J 2001; 17: 380-385 Year: 2001 Glitazones are associated with reduced risk of COPD exacerbations and mortality among patients with diabetes Source: Annual Congress 2011 - COPD: burden of disease, imaging and management Year: 2011 β-blockers and risk of COPD exacerbation requiring hospitalisation in patients with COPD Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011 Changes in physical activity and all-cause mortality in COPD Source: Eur Respir J 2014; 44: 1199-1209 Year: 2014 Initial treatment and mortality in COPD Source: Eur Respir J 2003; 22: Suppl. 45, 578s Year: 2003 CAB score predicts short-term mortality at hospital admission for acute exacerbations of COPD Source: International Congress 2017 – COPD management: new findings from large studies Year: 2017 Accelerated FEV1 decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients Source: Eur Respir J, 57 (3) 2000918; 10.1183/13993003.00918-2020 Year: 2021 Mortality predictors in COPD exacerbation Source: Annual Congress 2010 - COPD exacerbation Year: 2010 Risk factors for mortality in patients with COPD exacerbation Source: Annual Congress 2009 - Epidemiology of COPD Year: 2009 Evaluation of costs of inhospital treatment of COPD exacerbations Source: Eur Respir J 2004; 24: Suppl. 48, 64s Year: 2004